Skip to content

Safe Colorectal Surgery in the Elderly

Safe Surgery in the Elderly: A Review of Outcomes Following Robotic Proctectomy From the Nationwide Inpatient Sample, a Retrospective Cross Sectional Cohort Study. Cross-Sectional Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03765411
Enrollment
6740
Registered
2018-12-05
Start date
2013-01-01
Completion date
2017-04-15
Last updated
2018-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Cancer

Brief summary

The objective was to evaluate the use and outcomes of robotic proctectomy compared to open and laparoscopic approaches for rectal cancer in the elderly. A retrospective cross-sectional cohort study utilizing the Nationwide Inpatient Sample (NIS; 2006-2013) was performed.

Detailed description

The objective was to evaluate the use and outcomes of robotic proctectomy compared to open and laparoscopic approaches for rectal cancer in the elderly. A retrospective cross-sectional cohort study utilizing the Nationwide Inpatient Sample (NIS; 2006-2013) was performed. All cases were restricted to age 70 years old or greater. The incidence of robotic proctectomy from 2006 - 2013 both as a whole as well as divided into approach was analyzed. Each approach was compared for both primary and secondary outcomes.

Interventions

PROCEDUREProctectomy

Resection of the rectum

Sponsors

Madigan Army Medical Center
CollaboratorFED
Tripler Army Medical Center
Lead SponsorFED

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum

Inclusion criteria

* 70 years of age or older * underwent proctectomy

Exclusion criteria

* emergent admissions * abdominoperineal resections

Design outcomes

Primary

MeasureTime frameDescription
In-hospital Complicationsthrough study completion, an average of 5 daysComplications to include mechanical wound, infections, urinary, pulmonary, gastrointestinal, cardiovascular, systemic, surgical, and any complication

Secondary

MeasureTime frameDescription
In-hospital mortalitythrough study completion, an average of 5 daysDeath during admission
Length of Staythrough study completion, an average of 5 daysLength of in hospital stay
Costs and Chargesthrough study completion, an average of 5 daysHospital charges refer to the total amount billed by the hospital. Hospital cost refers to the amount paid by the insurance provider

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026